Pediatric rheumatology

Minor salivary gland biopsy in the diagnosis of definite ocular sarcoidosis in paediatric granulomatous uveitis

Pediatr Rheumatol Online JPublished Diagnostic accuracy study

Authors' conclusion

MSGB is useful to improve the diagnosis of OS and to reduce the incidence of uveitis considered idiopathic in PGU.

Study context

Population
Children with non-infectious paediatric granulomatous uveitis (PGU) diagnosed between 2018 and 2023
Participants
26 consecutive children
Comparison
Minor salivary gland biopsy (MSGB)+ vs MSGB-
  • MSGB+n = 12
Outcome
Utility of MSGB in the diagnosis of definite ocular sarcoidosis in PGU
Methodological detailsconsecutive children, systematically performed MSGB within 3 months of diagnosis
  • Consecutive children
  • Systematically performed MSGB within 3 months of diagnosis

Performance

As reported in the abstract

Diagnosis of definite ocular sarcoidosis
Test or modelValueSensitivityNPV
MSGB+46%92%93%

MSGB+

Value46%
Sensitivity92%
NPV93%
Definite ocular sarcoidosis (OS) diagnosed
13 of the 26 (50%)
Idiopathic uveitis
8 (31%)

Further findings

OutcomeP value
Characteristics MSGB+ vs MSGB-MSGB+ vs MSGB-P = 0.02
Characteristics MSGB+ vs MSGB-MSGB+ vs MSGB-P = 0.003
Characteristics MSGB+ vs MSGB-MSGB+ vs MSGB-P = 0.005
Characteristics MSGB+ vs MSGB-MSGB+ vs MSGB-P = 0.03

Most frequent extra-ocular organ involvement at OS diagnosis

Renal
46%
Thoracic
46%

Treatment · median follow-up 3.1 (0.6-6.3) years

First-line systemic corticosteroids
88%
Needed MTX and/or anti-TNF-alpha to achieve inactive uveitis
88%

Original publication

Minor salivary gland biopsy in the diagnosis of definite ocular sarcoidosis in paediatric granulomatous uveitis. Pediatr Rheumatol Online J. Published 10 March 2025. doi:10.1186/s12969-025-01078-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.